Fauci: Don't Rush Vaccine Without Overwhelming Data Of Effectiveness

The transcript discusses the safety and effectiveness of COVID-19 vaccines, emphasizing the ethical obligation to make vaccines available if interim results are positive. It highlights concerns about political pressure to approve vaccines prematurely and notes funding challenges for vaccine distribution. The transcript also mentions ongoing global vaccine trials by companies like AstraZeneca, Moderna, and Pfizer.

What is the moral obligation of clinical researchers if interim vaccine results are overwhelmingly positive?

• To make the vaccine available

• To ignore the results

• To delay the vaccine distribution

• To conduct more trials

Under what condition can clinical trials be ended early according to Fauci?

• If the results are overwhelmingly negative

• If the trials are too expensive

• If there is political pressure

• If the results are inconclusive

What concern did two medical scholars express in the New York Times?

• The vaccine may not be effective

• The vaccine may be too expensive

• The vaccine may not be safe

• The vaccine may be rushed before the election

What financial issue did the Kaiser Health News investigation highlight?

• Lack of funds for clinical trials

• Lack of funds for international distribution

• Lack of funds for public outreach and administration

• Lack of funds for vaccine development

Which companies have started advanced phase three vaccine trials in the US?

• AstraZeneca, Moderna, Pfizer BioNTech

• Sinovac, Bharat Biotech, CanSino

• Johnson & Johnson, Novavax, Sanofi

• GlaxoSmithKline, Merck, CureVac